US Patent 8445515 C5aR antagonists
Patent 8445515 was granted and assigned to ChemoCentryx on May, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08445515 C5aR antagonists US Patent 8445515 C5aR antagonists
Infobox
Patent Number
0844551500
Patent Number
844551500
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084455150
Date of Patent
May 21, 2013
0Patent Application Number
126432290
Date Filed
December 21, 2009
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084455150
Date of Patent
May 21, 2013
0Patent Application Number
126432290
Date Filed
December 21, 2009
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08445515 C5aR antagonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08445515
Date of patent
May 21, 2013
Patent application number
12643229
Date Filed
December 21, 2009
Patent primary examiner
Find more entities like US Patent 8445515 C5aR antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.